- Reaction score
- 135
I believe Stemson will as they are very close to finishing preclinicals, whereas Yokohama said they wanted to start clinical trials in 2023.One thing I'm curious about is who will succeed first when comparing Yokohama University to Stemson.
I particularly like Stemson's approach, it is more general, like Alexey said.
But I think a regeneration using hair follicle germs is something more doable in the short term.